Uripan 0.1% syrup 120 ml

Tradename:

Uripan

Yuripan

Compound:

Each 100 ml syrup contains:

Oxybutynin hydrochloride 0.1 g

Auxiliary components:

Sodium saccharin, microcrystalline cellulose, sodium metabisulphite, anise oil, glycerin, purified water.

Properties:

M-holinoblokator from the group of tertiary amines. Along with a moderate m-anticholinergic activity, it has the ability to directly affect the smooth muscles of the internal organs (myotropic antispasmodic effect). Eliminates spasms and lowers the tone of smooth muscles of internal organs: gastrointestinal tract, biliary tract, uterus, urinary tract, incl. Bladder. In a neurogenic bladder, oxybutynin relaxes the bladder detrusor, reduces spontaneous contractions of the detrusor, increases bladder capacity, and reduces the frequency of urination.

Indications:

Urinary incontinence due to instability of the bladder function of a neurogenic nature (detrusor hyperreflexia, for example, in multiple sclerosis or spina bifida), or idiopathic nature; nocturnal enuresis in children over 5 years of age (as monotherapy or in combination with other drugs).

Dosage and administration:

inside. 2.5 ml (half a teaspoon) 2 times a day. It is possible to increase the dose to 5 ml per day (1 teaspoon) 2 or 3 times a day. The last dose of the drug should be taken at bedtime.

Contraindications:

Violation of the outflow of urine from the bladder, when precipitation of retained urine is possible; intestinal obstruction; intestinal atony; severe ulcerative colitis; expansion of the colon; myasthenia gravis; glaucoma; lactation (breastfeeding); children’s age up to 5 years; hypersensitivity to oxybutynin.

Precautionary measures:

Use with caution in elderly patients, with NCD, impaired liver or kidney function, thyrotoxicosis, arrhythmias, coronary artery disease, chronic heart failure, arterial hypertension, initial manifestations of benign prostatic hyperplasia, UC, in patients with ileostomy, colostomy, and esophageal hernia openings of the diaphragm, accompanied by reflux esophagitis.

Side effects:

On the part of the digestive system: dry mouth, nausea, constipation, abdominal discomfort, diarrhea are possible.

From the side of the central nervous system: headache, drowsiness, dizziness, decreased visual acuity are possible.

Dermatological reactions: dry skin is possible.

Others: hot flashes are possible (more often in children), difficulty urinating, urinary retention, arrhythmias.

Storage method:

At a temperature not higher than 30 degrees. In a cool dry place.

Package:

The cardboard box holds a 120 ml bottle.